Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma
New Delhi: Improving access to new age medicines for obesity and diabetes over the next few years would be a key enabler for the growth of the domestic pharmaceutical industry,…
Lilly launches Mounjaro KwikPen in India
Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…
Popular diabetes drug, Mounjaro, launched in India
Mounjaro (tirzepatide): A breakthrough drug for the treatment of Type 2 diabetes and obesity, has been released in India. The drug has been approved by the Central Drugs Standard Control Organization…









